ABUS — Arbutus Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Arbutus Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.8	123	155	147	126
Net Total Accounts Receivable
Net Total Receivables	1.2	1.31	0.899	1.35	1.78
Prepaid Expenses
Total Current Assets	93.8	128	161	151	132
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.4	9.33	8.07	6.81	6.09
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	106	137	204	195	144
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.83	9.54	11.2	32.9	22.5
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	32.8	35.1	35	58.6	38.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	72.7	102	169	137	106
Total Liabilities & Shareholders' Equity	106	137	204	195	144
Total Common Shares Outstanding
Total Preferred Shares Outstanding